CY1110424T1 - Πρωτεϊνες ουροκορτινης και χρησεις αυτων - Google Patents
Πρωτεϊνες ουροκορτινης και χρησεις αυτωνInfo
- Publication number
- CY1110424T1 CY1110424T1 CY20081101461T CY081101461T CY1110424T1 CY 1110424 T1 CY1110424 T1 CY 1110424T1 CY 20081101461 T CY20081101461 T CY 20081101461T CY 081101461 T CY081101461 T CY 081101461T CY 1110424 T1 CY1110424 T1 CY 1110424T1
- Authority
- CY
- Cyprus
- Prior art keywords
- crf
- ucn
- urp
- human
- urocortin
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 102000005630 Urocortins Human genes 0.000 abstract 6
- 108010059705 Urocortins Proteins 0.000 abstract 6
- 239000000777 urocortin Substances 0.000 abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 101000658084 Homo sapiens U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 Proteins 0.000 abstract 3
- 101000841331 Homo sapiens Urotensin-2B Proteins 0.000 abstract 3
- 102000057476 human UTS2B Human genes 0.000 abstract 3
- 108091005470 CRHR2 Proteins 0.000 abstract 2
- 102100038019 Corticotropin-releasing factor receptor 2 Human genes 0.000 abstract 2
- 108090000189 Neuropeptides Proteins 0.000 abstract 2
- 101710166315 U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 Proteins 0.000 abstract 2
- 102100029789 Urocortin-2 Human genes 0.000 abstract 2
- 102100038018 Corticotropin-releasing factor receptor 1 Human genes 0.000 abstract 1
- 101710198652 Corticotropin-releasing factor receptor 1 Proteins 0.000 abstract 1
- 101000939391 Homo sapiens Urocortin Proteins 0.000 abstract 1
- 102000003797 Neuropeptides Human genes 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 235000021229 appetite regulation Nutrition 0.000 abstract 1
- 230000033228 biological regulation Effects 0.000 abstract 1
- 230000036760 body temperature Effects 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 102000053170 human UCN Human genes 0.000 abstract 1
- 230000004179 hypothalamic–pituitary–adrenal axis Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- ZEBBPGHOLWPSGI-KPLDDXDLSA-N urocortin ii Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(N)=O)CC1=CN=CN1 ZEBBPGHOLWPSGI-KPLDDXDLSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Wood Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Physics & Mathematics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22325500P | 2000-08-04 | 2000-08-04 | |
| US27396901P | 2001-03-07 | 2001-03-07 | |
| EP01963759A EP1305334B1 (en) | 2000-08-04 | 2001-07-31 | Urocortin proteins and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1110424T1 true CY1110424T1 (el) | 2015-04-29 |
Family
ID=26917597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20081101461T CY1110424T1 (el) | 2000-08-04 | 2008-12-17 | Πρωτεϊνες ουροκορτινης και χρησεις αυτων |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US6838274B2 (https=) |
| EP (1) | EP1305334B1 (https=) |
| JP (1) | JP4873825B2 (https=) |
| KR (1) | KR100879232B1 (https=) |
| CN (1) | CN1484650B (https=) |
| AT (1) | ATE408622T1 (https=) |
| AU (2) | AU2001284683B2 (https=) |
| CA (1) | CA2418144C (https=) |
| CY (1) | CY1110424T1 (https=) |
| DE (1) | DE60135850D1 (https=) |
| DK (1) | DK1305334T3 (https=) |
| ES (1) | ES2313978T3 (https=) |
| IL (2) | IL154102A0 (https=) |
| PT (1) | PT1305334E (https=) |
| RU (1) | RU2278871C2 (https=) |
| WO (1) | WO2002012307A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1305334T3 (da) * | 2000-08-04 | 2009-02-02 | Res Dev Foundation | Urocortinproteiner og anvendelser deraf |
| US20020082409A1 (en) * | 2000-10-26 | 2002-06-27 | Hsu Sheau Yu | Stresscopins and their uses |
| US6670140B2 (en) * | 2001-03-06 | 2003-12-30 | The Procter & Gamble Company | Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| US6812210B2 (en) | 2001-03-15 | 2004-11-02 | Research Development Foundation | Urocortin-III and uses thereof |
| US7192924B2 (en) | 2002-01-16 | 2007-03-20 | The Procter & Gamble Company | Corticotropin releasing factor 2 receptor agonists |
| US7982018B2 (en) * | 2006-10-16 | 2011-07-19 | Conjuchem, Llc | Modified corticotropin releasing factor peptides and uses thereof |
| WO2008157302A2 (en) | 2007-06-13 | 2008-12-24 | Research Development Foundation | Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating crf receptor signaling |
| AU2008297411A1 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| US20100204113A1 (en) * | 2007-09-11 | 2010-08-12 | Dorian Bevec | Use of stresscopin-related peptide as a therapeutic agent |
| WO2011025905A1 (en) * | 2009-08-28 | 2011-03-03 | Research Development Foundation | Urocortin 2 analogs and uses thereof |
| WO2013063046A1 (en) | 2011-10-24 | 2013-05-02 | Research Development Foundation | Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors |
| CN108310396B (zh) | 2012-02-14 | 2022-07-15 | 加利福尼亚大学董事会 | 用于心血管疾病和其它病况的旁分泌基因的全身性递送和受调节的表达 |
| JOP20170153A1 (ar) * | 2016-07-15 | 2019-01-30 | Lilly Co Eli | نظائر urocortin-2 جديدة معدلة بحمض دهني لعلاج داء السكري وأمراض الكلى المزمنة |
| US12472158B2 (en) | 2019-02-27 | 2025-11-18 | Vanderbilt University | Methods of treating trigeminal nerve pain |
| CN110826145B (zh) * | 2019-09-09 | 2020-08-28 | 西安工业大学 | 基于超启发式马氏链进化的汽车多参数运行工况设计方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0845035A2 (en) | 1995-06-13 | 1998-06-03 | The Salk Institute For Biological Studies | Urocortin peptides |
| DK1305334T3 (da) * | 2000-08-04 | 2009-02-02 | Res Dev Foundation | Urocortinproteiner og anvendelser deraf |
| US20020082409A1 (en) | 2000-10-26 | 2002-06-27 | Hsu Sheau Yu | Stresscopins and their uses |
| US6670140B2 (en) * | 2001-03-06 | 2003-12-30 | The Procter & Gamble Company | Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
-
2001
- 2001-07-31 DK DK01963759T patent/DK1305334T3/da active
- 2001-07-31 ES ES01963759T patent/ES2313978T3/es not_active Expired - Lifetime
- 2001-07-31 AU AU2001284683A patent/AU2001284683B2/en not_active Ceased
- 2001-07-31 AU AU8468301A patent/AU8468301A/xx active Pending
- 2001-07-31 DE DE60135850T patent/DE60135850D1/de not_active Expired - Lifetime
- 2001-07-31 EP EP01963759A patent/EP1305334B1/en not_active Expired - Lifetime
- 2001-07-31 PT PT01963759T patent/PT1305334E/pt unknown
- 2001-07-31 WO PCT/US2001/023976 patent/WO2002012307A1/en not_active Ceased
- 2001-07-31 IL IL15410201A patent/IL154102A0/xx unknown
- 2001-07-31 US US09/919,473 patent/US6838274B2/en not_active Expired - Lifetime
- 2001-07-31 CN CN018157831A patent/CN1484650B/zh not_active Expired - Fee Related
- 2001-07-31 CA CA2418144A patent/CA2418144C/en not_active Expired - Fee Related
- 2001-07-31 AT AT01963759T patent/ATE408622T1/de active
- 2001-07-31 JP JP2002518278A patent/JP4873825B2/ja not_active Expired - Fee Related
- 2001-07-31 KR KR1020037001559A patent/KR100879232B1/ko not_active Expired - Fee Related
- 2001-07-31 RU RU2003105897/13A patent/RU2278871C2/ru not_active IP Right Cessation
-
2003
- 2003-01-23 IL IL154102A patent/IL154102A/en not_active IP Right Cessation
-
2004
- 2004-10-25 US US10/973,092 patent/US7223846B2/en not_active Expired - Lifetime
-
2007
- 2007-04-05 US US11/784,317 patent/US7638607B2/en not_active Expired - Fee Related
-
2008
- 2008-12-17 CY CY20081101461T patent/CY1110424T1/el unknown
-
2009
- 2009-12-07 US US12/632,715 patent/US8044025B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL154102A0 (en) | 2003-07-31 |
| IL154102A (en) | 2010-12-30 |
| EP1305334B1 (en) | 2008-09-17 |
| RU2003105897A (ru) | 2005-01-20 |
| ES2313978T3 (es) | 2009-03-16 |
| US20100168021A1 (en) | 2010-07-01 |
| US20020127221A1 (en) | 2002-09-12 |
| WO2002012307A1 (en) | 2002-02-14 |
| CN1484650B (zh) | 2012-12-12 |
| ATE408622T1 (de) | 2008-10-15 |
| DE60135850D1 (de) | 2008-10-30 |
| US6838274B2 (en) | 2005-01-04 |
| US7223846B2 (en) | 2007-05-29 |
| DK1305334T3 (da) | 2009-02-02 |
| AU2001284683B2 (en) | 2006-04-27 |
| US8044025B2 (en) | 2011-10-25 |
| EP1305334A4 (en) | 2005-03-23 |
| RU2278871C2 (ru) | 2006-06-27 |
| AU8468301A (en) | 2002-02-18 |
| KR100879232B1 (ko) | 2009-01-20 |
| EP1305334A1 (en) | 2003-05-02 |
| US7638607B2 (en) | 2009-12-29 |
| PT1305334E (pt) | 2008-12-30 |
| KR20030074589A (ko) | 2003-09-19 |
| JP4873825B2 (ja) | 2012-02-08 |
| CA2418144A1 (en) | 2002-02-14 |
| CA2418144C (en) | 2013-06-18 |
| US20070191592A1 (en) | 2007-08-16 |
| CN1484650A (zh) | 2004-03-24 |
| JP2004505640A (ja) | 2004-02-26 |
| US20050191650A1 (en) | 2005-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110424T1 (el) | Πρωτεϊνες ουροκορτινης και χρησεις αυτων | |
| Lee et al. | Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. | |
| Wistow | Domain structure and evolution in α-crystallins and small heat-shock proteins | |
| ATE358724T1 (de) | Expression regulierende sequenzen vom schimmelpilz chrysosporium | |
| DE60335726D1 (de) | Chromoprotein und fluoroproteine | |
| DK1908772T3 (da) | Polypeptider og polynucleinsyrer af phorphorymonas gingivalis | |
| Lee et al. | A sapecin homologue of Holotrichia diomphalia: purification, sequencing and determination of disulfide pairs | |
| FI930626A0 (fi) | Proteinstruktur hos vaexttoxingelonin | |
| DK0594771T3 (da) | Cycloheximidresistens i nukleotidsekvenser og -proteiner | |
| EP1117682A4 (en) | Novel peptides | |
| DE69935599D1 (de) | Modifizierte hcv peptid-impfstoffe | |
| Reid | Amino acid sequence of the N-terminal forty-two amino acid residues of the C chain of subcomponent C1q of the first component of human complement | |
| Leszyk et al. | Amino acid sequence of a 15 kilodalton actin-binding fragment of turkey gizzard caldesmon: Similarity with dystrophin, tropomysin and the tropomyosin-binding region of troponin T | |
| ES2164297T3 (es) | Preparacion de (poli)peptidos purificados. | |
| ATE449107T1 (de) | Aus fisch gewonnene peptide und nukleinsäuren der cathelicidin familie und deren verwendung | |
| ATE281519T1 (de) | Klonierung und rekombinante herstellung des crf- rezeptors (crf=corticotropin ausloese faktor) | |
| ATE389720T1 (de) | Nierenspezifischer urattransporter und dessen gen | |
| Tanaka et al. | Heterogeneity of the principal sigma factor in Escherichia coli: The rpoS gene product, sigma super (38), is a second principal sigma factor of RNA polymerase in stationary-phase Escherichia coli. | |
| WO2007058267A8 (ja) | 新規タンパク質及びそれをコードする遺伝子 | |
| Smith et al. | Disulfide bonds in a recombinant protein modeled after a core repeat in an aquatic insect's silk protein | |
| Strasser et al. | Variable and constant regions in the C‐terminus of vinculin and metavinculin: Cloning and expression of fragments in E. coli | |
| Brandt et al. | Variants of wheat histone H1 with N-and C-terminal extensions | |
| Tchouatcha-Tchouassom et al. | Isolation and characterisation of five histone H1 subtypes from adult rat liver | |
| WO2004013167A3 (en) | Purified polypeptides from enterococcus faecalis | |
| DE69731312D1 (de) | Peptide spezifisch für antikörper gegen peptidconcensussequenzen aus der cs4-cfa/iprpteinfamilie |